Aries Wealth Management Abb Vie Inc. Transaction History

Aries Wealth Management

$359 Million
Q3 2024

A detailed history of Aries Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Aries Wealth Management holds 13,532 shares of ABBV stock, worth $2.44 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

13,532

Previous 13,064 3.58%

Holding current value

$2.44 Million

Previous $2.24 Million 19.29%

% of portfolio

0.74%

Previous 0.71%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$163.84 - $199.33 $76,677 - $93,286	468 Added 3.58%	13,532 $2.67 Million
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $2,476 - $2,892	16 Added 0.12%	13,064 $2.24 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $4,794 - $5,463	-30 Reduced 0.23%	13,048 $2.38 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $25,043 - $28,204	-182 Reduced 1.37%	13,078 $2.03 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $71,470 - $82,737	535 Added 4.2%	13,260 $1.98 Million
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $25,306 - $29,144	175 Added 1.39%	12,725 $2.03 Million
Q4 2022 Jan 18, 2023	BUY	$138.31 - $165.87 $20,746 - $24,880	150 Added 1.21%	12,550 $0
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $20,399 - $23,397	152 Added 1.24%	12,400 $1.82 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $1.69 Million - $2.14 Million	12,248 New	12,248 $1.88 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $1.6 Million - $1.98 Million	-12,098 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$107.43 - $135.93 $7.8 Million - $9.87 Million	-72,588 Reduced 85.71%	12,098 $1.64 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $7.82 Million - $9.89 Million	72,748 Added 609.38%	84,686 $11.5 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $3,724 - $4,227	35 Added 0.29%	11,938 $1.29 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $14,203 - $15,823	135 Added 1.15%	11,903 $1.34 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $209,510 - $230,645	2,048 Added 21.07%	11,768 $1.25 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $22,011 - $29,454	300 Added 3.18%	9,720 $954,000
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $64,500 - $97,790	-1,000 Reduced 9.6%	9,420 $708,000
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $88,172 - $106,008	-1,400 Reduced 11.84%	10,420 $767,000
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $46,284 - $54,474	-600 Reduced 4.83%	11,820 $953,000
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $85,291 - $100,918	-950 Reduced 7.11%	12,420 $1.15 Million
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $18,586 - $24,888	-202 Reduced 1.49%	13,370 $1.25 Million
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $1.22 Million - $1.33 Million	13,572	13,572 $1.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.

Account

Aries Wealth Management Abb Vie Inc. Transaction History